HIV / AIDS in the News

The Trump Administration’s Foreign Aid Review: Status of PEPFAR - KFF

 

Tumour-like tissue environments offer new target for HIV cure research - BioSpectrum Asia

 

New research highlights hidden metabolic risks in non-obese HIV patients - News-Medical

 

Long-acting HIV prevention tools could help close the gap before a vaccine arrives - News-Medical

 

[AIDS 2026] MedPage Today: Cabotegravir HIV PrEP effective among US women despite treatment interruptions - European AIDS Treatment Group

 

Health and Human Rights journal: Key populations under threat: A central theme at AIDS 2026 - European AIDS Treatment Group

 

Disgraced Florida pastor allegedly had sex with young teen 3 times — and failed to mention he was HIV positive - New York Post

 

Beyond AIDS 2026: AVAC’s Top 10 - avac.org

 

[AIDS 2026] City St George's, University of London: Risk of death 21% lower in people with HIV-related fungal disease given combination drug treatment - European AIDS Treatment Group

 

HIV i-Base: AIDS 2026: New HIV drugs in the ART pipeline - European AIDS Treatment Group

 

HIV Justice Network at AIDS 2026: Two posters on HIV criminalisation - European AIDS Treatment Group

 

Autologous Stem Cell Transplantation (ASCT) for HIV-Associated Lymphoma: Latest Evidence - Oncodaily

 

Florida pastor accused of having sex with 14-year-old boy while hiding HIV diagnosis - NBC Connecticut

 

Experts Establish Pillars of Care for Older Adults With HIV - MedPage Today

 

New monthly HIV prevention pill, in late-stage trials, could provide a giant step forward in stopping new HIV infections - UNAIDS

 

GILD Q2 Deep Dive: Pipeline Expansion and HIV Portfolio Drive Growth Amid Margin Pressure - stockstory.org

 

New model maps where HIV is concentrated and the disease is more advanced - Medical Xpress

 

Florida pastor charged with abusing teen boy and allegedly exposing him to HIV - TheGrio

 

Gilead (GILD) Faces HIV Drug Access Criticism From AIDS Healthcare Foundation - Yahoo Finance

 

[AIDS 2026] Africa Health Research Institute: Mobile Men study: injectable PrEP beats pills for men who travel for work - European AIDS Treatment Group

 

Once-weekly HIV pill as effective as daily dose, research shows - The Conversation

 

HIV cases continue in Penobscot County, Maine CDC reports - WABI

 

UN Summit on HIV/AIDS Shows Incredible Progress in Infection Rates, Deaths, Treatment Access - Good News Network

 

GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised - Yahoo Finance

 

Zimbabweans Fleeing Xenophobia In South Africa Battle To Get HIV Medicine Back Home - healthpolicy-watch.news

 

Northern Light EMMC ramps up HIV prevention efforts amid case increase - newscentermaine.com

 

Hypertension Identified in Nearly Half of HAART Patients - EMJ

 

Northwestern University: Tumor-like tissue environments could hold clues to curing HIV - European AIDS Treatment Group

 

Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV - HealthDay

 

Gilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability - Fierce Pharma